Small-molecule tyrosine kinase inhibitor that targets Kit, KDR (VEGFR2), and CSF-1R (c-Fms), with reported IC50s of ~80 nM, 9 nM, and 15 nM, respectively. Supplied as a high-purity research compound (CAS 728033-96-3; formula C22H16F3N3O2S; MW 443.44 g/mol).
- Selective inhibition of Kit, KDR (VEGFR2), and CSF-1R at low nanomolar concentrations.
- Demonstrates antitumor activity in preclinical studies.
- Suitable for biochemical kinase assays and cell-based signaling studies.
- Provided as a high-purity compound for research applications.
- Defined molecular weight and formula for accurate dosing and calculations.